Advertisement
American Journal of Kidney Diseases

Predialysis Serum Sodium Level, Dialysate Sodium, and Mortality in Maintenance Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS)

Published:September 26, 2011DOI:https://doi.org/10.1053/j.ajkd.2011.07.013

      Background

      Predialysis serum sodium concentrations recently have been linked to patient characteristics and outcomes in hemodialysis patients and may have implications for the dialysate sodium prescription.

      Study Design

      Prospective cohort study.

      Participants

      11,555 patients from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS), phases I (1996-2001) and III (2005-2008).

      Predictors

      Demographics, comorbid conditions, laboratory measurements (model 1); mean serum sodium level, dialysate sodium concentration (model 2).

      Outcomes

      Serum sodium level, using adjusted linear mixed models (model 1); all-cause mortality, using Cox proportional hazards models (model 2).

      Results

      Median follow-up was 12 months, with 1,727 deaths (15%) occurring during the study period (12,274 patient-years). Mean serum sodium level in the DOPPS countries was 138.5 ± 2.8 mEq/L. Japan had the highest (139.1 ± 2.6 mEq/L) and Australia/New Zealand had the lowest mean serum sodium level (137.4 ± 2.8 mEq/L). Serum sodium level was associated positively with male sex, black race, body mass index, serum albumin level, and creatinine level and negatively with neurologic and psychiatric disease, white blood cell count, and intradialytic weight loss (0.16 mEq/L lower per 1% loss). Higher serum sodium level was associated with lower adjusted all-cause mortality in a continuous model (HR, 0.95 per 1 mEq/L higher; 95% CI, 0.93-0.97). Dialysate sodium prescription was not associated with serum sodium level. Mortality analyses restricted to the serum sodium tertile with the highest mortality (serum sodium <137 mEq/L) showed lower mortality risk in patients with dialysate sodium prescriptions >140 mEq/L.

      Limitations

      Causality cannot be established in this observational study, which does not consider potential effects of dialysate sodium level on postdialysis thirst, dietary salt and water intake, interdialytic weight gain, and cardiovascular stability.

      Conclusions

      Lower serum sodium levels are associated with certain hemodialysis patient characteristics and higher adjusted risk of death. The lower mortality observed in our adjusted analyses in patients with serum sodium levels <137 mEq/L dialyzed against dialysate sodium prescriptions >140 mEq/L is intriguing, may be related to intradialytic cardiovascular stability, and deserves further study.

      Index Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Kidney Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Adrogue H.J.
        • Madias N.E.
        Sodium and potassium in the pathogenesis of hypertension.
        N Engl J Med. 2007; 356: 1966-1978
        • Braunwald E.
        • Plauth Jr, W.H.
        • Morrow A.G.
        A method for the detection and quantification of impaired sodium excretion.
        Circulation. 1965; 32: 223-231
        • Hollenberg N.K.
        Set point for sodium homeostasis: surfeit, deficit, and their implications.
        Kidney Int. 1980; 17: 423-429
        • Strauss M.B.
        • Lamdin E.
        • Smith W.P.
        • Bleifer D.J.
        Surfeit and deficit of sodium; a kinetic concept of sodium excretion.
        AMA Arch Intern Med. 1958; 102: 527-536
        • Flanigan M.J.
        Role of sodium in hemodialysis.
        Kidney Int Suppl. 2000; 76: S72-S78
        • Keen M.L.
        • Gotch F.A.
        The association of the sodium “setpoint” to interdialytic weight gain and blood pressure in hemodialysis patients.
        Int J Artif Organs. 2007; 30: 971-979
        • Levin N.W.
        • Zhu F.
        • Keen M.
        Interdialytic weight gain and dry weight.
        Blood Purif. 2001; 19: 217-221
        • de Paula F.M.
        • Peixoto A.J.
        • Pinto L.V.
        • Dorigo D.
        • Patricio P.J.
        • Santos S.F.
        Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients.
        Kidney Int. 2004; 66: 1232-1238
        • Santos S.F.
        • Peixoto A.J.
        Revisiting the dialysate sodium prescription as a tool for better blood pressure and interdialytic weight gain management in hemodialysis patients.
        Clin J Am Soc Nephrol. 2008; 3: 522-530
        • Munoz Mendoza J.
        • Sun S.
        • Chertow G.M.
        • Moran J.
        • Doss S.
        • Schiller B.
        Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach?.
        Nephrol Dial Transplant. 2011; 26: 1281-1287
        • Hecking M.
        • Kainz A.
        • Horl W.H.
        • Herkner H.
        • Sunder-Plassmann G.
        Sodium setpoint and sodium gradient: influence on plasma sodium change and weight gain.
        Am J Nephrol. 2011; 3: 39-48
        • Saran R.
        • Bragg-Gresham J.L.
        • Rayner H.C.
        • et al.
        Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS.
        Kidney Int. 2003; 64: 254-262
        • Kalantar-Zadeh K.
        • Regidor D.L.
        • Kovesdy C.P.
        • et al.
        Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis.
        Circulation. 2009; 119: 671-679
        • Agarwal R.
        Management of hypertension in hemodialysis patients.
        Hemodial Int. 2006; 10: 241-248
        • Charra B.
        Fluid balance, dry weight, and blood pressure in dialysis.
        Hemodial Int. 2007; 11: 21-31
        • Jindal K.
        • Chan C.T.
        • Deziel C.
        • et al.
        Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology.
        J Am Soc Nephrol. 2006; 17: S1-S27
        • Wystrychowski G.
        • Levin N.W.
        Dry weight: sine qua non of adequate dialysis.
        Adv Chronic Kidney Dis. 2007; 14: e10-e16
        • Lomonte C.
        • Basile C.
        Do not forget to individualize dialysate sodium prescription.
        Nephrol Dial Transplant. 2011; 26: 1126-1128
        • Penne E.L.
        • Sergeyeva O.
        Sodium gradient: a tool to individualize dialysate sodium prescription in chronic hemodialysis patients?.
        Blood Purif. 2011; 31: 86-91
        • Lindley E.J.
        Reducing sodium intake in hemodialysis patients.
        Semin Dial. 2009; 22: 260-263
        • Port F.K.
        • Johnson W.J.
        • Klass D.W.
        Prevention of dialysis disequilibrium syndrome by use of high sodium concentration in the dialysate.
        Kidney Int. 1973; 3: 327-333
        • Waikar S.S.
        • Curhan G.C.
        • Brunelli S.M.
        Mortality associated with low serum sodium concentration in maintenance hemodialysis.
        Am J Med. 2011; 124: 77-84
        • Pisoni R.L.
        • Gillespie B.W.
        • Dickinson D.M.
        • Chen K.
        • Kutner M.H.
        • Wolfe R.A.
        The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology.
        Am J Kidney Dis. 2004; 44: 7-15
        • Young E.
        • Goodkin D.A.
        • Mapes D.L.
        • et al.
        The Dialysis Outcomes and Practice Patterns Study (DOPPS): an international hemodialysis study.
        Kidney Int Suppl. 2000; 57: S74-S81
        • Robinson B.M.
        • Port F.K.
        Caring for dialysis patients: international insights from the Dialysis Outcomes and Practice Patterns Study (DOPPS).
        Semin Dial. 2010; 23: 4-6
        • Katz M.A.
        Hyperglycemia-induced hyponatremia—calculation of expected serum sodium depression.
        N Engl J Med. 1973; 289: 843-844
        • Penne E.L.
        • Thijssen S.
        • Raimann J.G.
        • Levin N.W.
        • Kotanko P.
        Correction of serum sodium for glucose concentration in hemodialysis patients with poor glucose control.
        Diabetes Care. 2010; 33: e91
        • Lin D.
        • Wei L.
        • Ying Z.
        Checking the Cox model with cumulative sums of Martingale-based residuals.
        Biometrika. 1993; 80: 557-572
        • Lago R.M.
        • Pencina M.J.
        • Wang T.J.
        • et al.
        Interindividual variation in serum sodium and longitudinal blood pressure tracking in the Framingham Heart Study.
        J Hypertens. 2008; 26: 2121-2125
        • Sergeyeva O.
        • Usvyat L.
        • Kotanko P.
        • Levin N.
        Positive intradialytic sodium gradients relate to increasing intradialytic weight gain, hospitalization rate, and mortality in chronic hemodialysis patients.
        WCN Poster NDT Plus. 2009; 2: iii650
        • Holbek C.C.
        Understanding the different values in electrolyte measurements.
        (Accessed August 20, 2010)
        • Flythe J.E.
        • Kimmel S.E.
        • Brunelli S.M.
        Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality.
        Kidney Int. 2011; 79: 250-257
        • Saran R.
        • Bragg-Gresham J.L.
        • Levin N.W.
        • et al.
        Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS.
        Kidney Int. 2006; 69: 1222-1228